Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis

Thrombosis and Haemostasis

Volumn 110, Issue 4, 2013, Pages 761-768

  Matsumoto, Tomoko ^a   Nogami, Keiji ^a   Shima, Midori ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Coagulation; Fibrinolysis; Global haemostatic assay; Plasmin generation; Thrombin generation

Indexed keywords

ACTIVATED PROTEIN C; ARGATROBAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PLASMIN; PLASMINOGEN; THROMBIN; THROMBOMODULIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HEMOPHILIA A; HEMOSTASIS; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; THROMBIN TIME;

COAGULATION; FIBRINOLYSIS; GLOBAL HAEMOSTATIC ASSAY; PLASMIN GENERATION; THROMBIN GENERATION;

AFIBRINOGENEMIA; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CONJUNCTIVITIS; FACTOR V DEFICIENCY; FACTOR X DEFICIENCY; FEEDBACK, PHYSIOLOGICAL; FIBRINOLYSIN; FIBRINOLYSIS; HEMOPHILIA A; HEMOSTASIS; HUMANS; PLASMINOGEN; PROTEIN C INHIBITOR; SKIN DISEASES, GENETIC; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84884857875     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-04-0345     Document Type: Article

References (20)

1. Sorensen B, Johansen P, Christiansen K, et al. Whole blood coagulation throm-belastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-558.
2. Hemker HC, Wielder S, Kessels H, et al. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-624.
3. Hemker HC, Giesen PL, Ramjee M, et al. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 589-591.
4. Wagenvoord RJ, Hendrix HH, Kai H, et al. A chromogenic test to determine the procoagulant phospholipids in platelet-rich plasma and whole blood. Thromb Haemost 1994; 72: 582-587.
5. van Hylckama Vlieg A, Christiansen SC, Luddington R, et al. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol 2007; 138: 769-774.
6. Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. J Am Med Assoc 2006; 296: 397-402.
7. Dargaud Y, Beguin S, Lienhart A, et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-480.
8. Matsumoto T, Nogami K, Ogiwara K, et al. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies. Thromb Haemost 2012; 107: 288-301.
9. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999; 94: 2169-2178.
10. Goldenberg NA, Hathaway WE, Jacobson L, et al. A new global assay of coagulation and fibrinolysis. Thromb Res 2005; 116: 345-356.
11. Simpson ML, Goldenber NA, Jacobson LJ, et al. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thromb Res 2011; 127: 317-332.
12. Van Geffen M, Loof A, Lap P, et al. A novel haemostasis assay for the simultaneous measurement of coagulation and fibrinolysis. Hematology 2011; 16: 327-336.
13. Mimms LT, Zampighi G, Nozaki Y, et al. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry 1981; 20: 833-840.
14. Hemker HC, Willems GM, Beguin S. A computer assisted methods to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay process. Thromb Haemost 1986; 56: 9-17.
15. Leurs J, Nerme V, Sim Y, et al. Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism. J Thromb Haemost 2004; 2: 416-423.
16. Matsumoto T, Shima M, Takeyama M, et al. The measurement of low levels of factor VIII or factor IX in haemophilia A and haemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 2006; 4: 377-384.
17. Matsumoto T, Nogami K, Ogiwara K, et al. A modified thrombin generation test for investigating very low levels of factor VIII activity in haemophilia A. Int J Hematol 2009; 90: 576-582.
18. Wagenvoord RJ, Deinum J, Elg M, et al. The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha(2)-macroglobulin-thrombin. J Thromb Haemost 2010; 8: 1281-1289.
19. Broze GJ Jr, Higuchi DA. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and premature lysis of from haemophilic plasma. Blood 1996; 88: 3815-3823.
20. Mosnier LO, Lisman T, van den Berg HM, et al. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001; 86: 1035-1039.